After seven years in this industry, the one question I hear time and again is: ‘How can we speed this up?’ And while payers won’t hand out fast passes, there are definitely ways to streamline the process and make it a bit smoother.
FOLLOW US
Priority Healthcare Consulting
Quantitative Market Research For Expedited Pharmaceutical Uptake
expediting pharmaceutical development
Our Services
We provide exceptional quantitative market research, leveraging our internal experts who have spent their entire careers in pharmaceutical market research. We uncover barriers, risks, and opportunities for your therapeutic product, predict market share with our proprietary forecasting method, and provide strategic direction on how to maximize your market share within that market. We are highly experienced market researchers who deliver high-quality results and exceed expectations on every project.
Market Access Forecasting
Current market access strategies are focused on contracting, distribution, and optimizing coverage restrictions on policies. While these are critical market access functions, there are not enough resources dedicated to maximizing uptake during the initial stage of new drug launches, which can be detrimental to a new drug's success.
New drugs face insurance coverage blocks for 3 to 12 months at launch. Many manufacturers make incorrect assumptions about the best way to address these barriers, leading to revenue loss and slower product uptake. Slower uptake has numerous negative downstream business implications, such as prescribers abandoning the product in favor of a competitor. This can be true even if the manufacturer’s product has a compelling attribute-benefit mix compared to its competitors.
With our proprietary forecasting market access method, we will build a model tailored to your launch that addresses these initial coverage barriers and shows you how to circumvent them.
Sequencing Prescriber Demand Forecast
We consult on how to identify market drivers of share for prescribers.
With our proprietary forecasting method, we can build a patient population that accurately reflects the therapeutic landscape. Physicians treat simulated patients that mirror real-world market conditions for the disease.
By sequencing outcomes after each treatment selection, we can identify key drivers related to patients, physicians, and product attributes for both your product and all competitors. This is especially critical in therapeutic areas such as oncology, where later-line treatments depend on earlier treatment selections.
Market Access Payer Messaging Strategy
Conducting custom market research with payers presents unique challenges, as payer objectives often diverge significantly from those of manufacturers. Our approach centers on analyzing real-world examples and analogs in payer messaging. By examining payer priorities we align our research to reveal actionable insights that meet their needs. We highlight missteps from other manufacturers, using them as learning points, and emphasize strategies that have proven successful. This allows us to navigate payer landscapes more effectively, building strategies that resonate with their goals and strengthen your market access.
Free resources
Latest Articles
Join our Newsletter to Receive Actionable Insights on Getting Products to Market Faster
Copyright 2024. Priority Healthcare Consulting | All rights reserved